The Trial Innovation Network (TIN) is a collaborative effort within the Clinical and Translational Science Award (CTSA) program designed to speed up the translation of new breakthroughs and interventions in life-saving strategies used in clinical settings. TIN is a response to the numerous roadblocks clinical investigators face when planning and ultimately conducting clinical trials. This national collaborative network seeks to pave the way for clinical investigators to perform multi-site studies in better, faster and more economical ways.
What follows is a brief question and answer overview of this clinical investigator-centric organization.
Who Started the Trial Innovation Network?
It was started by the Clinical and Translational Science Award (CTSA) program which was formed by the U.S. federal government under the National Institute of Health’s National Center for Advancing Translational Sciences (NCATS).
Why was TIN Formed?
It was formed to speed up the translation of new breakthroughs and interventions into life-saving strategies used in clinical settings. It would appear that there is a growing emphasis on supporting multi-site studies with an emphasis on trial...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).